Are you over 18 and want to see adult content?
More Annotations
A complete backup of theportalist.com
Are you over 18 and want to see adult content?
A complete backup of orientcities.com
Are you over 18 and want to see adult content?
A complete backup of angelique-india.com
Are you over 18 and want to see adult content?
A complete backup of unterkleid.tumblr.com
Are you over 18 and want to see adult content?
A complete backup of stgabrielvalreas.fr
Are you over 18 and want to see adult content?
A complete backup of scissorvixens.com
Are you over 18 and want to see adult content?
A complete backup of bearsoapcompany.com
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of jsonschema2pojo.org
Are you over 18 and want to see adult content?
A complete backup of xn--glsersplmaschine-wnb15b.de
Are you over 18 and want to see adult content?
A complete backup of weingut-beck.net
Are you over 18 and want to see adult content?
A complete backup of scribecopywriting.com.au
Are you over 18 and want to see adult content?
A complete backup of nhathuocdoctorhelp.com
Are you over 18 and want to see adult content?
Text
HUMIRA COMPLETE
HUMIRA can be used alone or with certain other medicines. HUMIRA may prevent further damage to your bones and joints and may help your ability to perform daily activities. Ankylosing spondylitis (AS) in adults. Moderate to severe hidradenitis suppurativa (HS) in people 12years and older.
HUMIRA® (ADALIMUMAB) FOR CHILDREN WITH ULCERATIVE COLITIS HUMIRA is the first and only treatment in its category that is FDA approved for pediatric ulcerative colitis (UC), and that can be administered at home after proper training by a health care professional. Over 1.4 million people worldwide are currently being treated with HUMIRA for different conditions. HUMIRA has been studiedfor more than 17
HUMIRA® (ADALIMUMAB) & NOVEL CORONAVIRUS (COVID-19) HUMIRA can cause serious side effects, including: Serious infections. These include TB and infections caused by viruses, fungi, or bacteria. Symptoms related to TB include a cough, low-grade fever, weight loss, or loss of body fat and muscle. Hepatitis B infection in carriers ofthe virus.
HUMIRA DOSING INFORMATION The starting dose of HUMIRA for adult patients with plaque psoriasis is 80 mg (milligrams) on Day 1 (2 Pens). The maintenance dose is 40 mg on Day 8 (1 Pen), and 40 mg every other week thereafter. Always follow your doctor's instructions about when and how often to take HUMIRA. If you need additional help with self-injecting, you can view an HUMIRA® (ADALIMUMAB) CITRATE-FREE INJECTION The latest HUMIRA presentation, Citrate-free, works just like original HUMIRA, but with less pain immediately following injection.*. The active ingredient (adalimumab) is the same as it has been for over 15 years. Other enhancements include a thinner needle and 50% less liquid to inject compared to original HUMIRA. HOW TO INJECT YOUR HUMIRA® (ADALIMUMAB) PEN OR SYRINGE Do not remove the gray or the plum-colored caps until right before your injection. When the plum-colored button on the HUMIRA Pen is pressed to give your dose of HUMIRA, you will hear a loud "click." The loud “click” means the injection has started. Injection is complete when the yellow indicator fully appears in the window viewand stops
IMPORTANT SAFETY INFORMATION Learn about the most common side effects of HUMIRA. Common side effects of HUMIRA include injection site reactions (pain, redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, rash, and nausea. These are not all of the possible side effects with HUMIRA. Tell your doctor if you haveany side
UVEITIS (UV) & HUMIRA® (ADALIMUMAB) HUMIRA can cause serious side effects, including: Serious infections. These include TB and infections caused by viruses, fungi, or bacteria. Symptoms related to TB include a cough, low-grade fever, weight loss, or loss of body fat and muscle. Hepatitis B infection in carriers ofthe virus.
FREQUENTLY ASKED QUESTIONS ABOUT HUMIRA (ADALIMUMAB) HUMIRA is a medicine called a tumor necrosis factor (TNF) blocker. HUMIRA targets and blocks TNF-alpha. TNF plays a role in the process that causes inflammation. Because TNF blockers, including HUMIRA, affect the immune system, they can lower the ability to fight infections and may cause other serious side effects. HUMIRA® (ADALIMUMAB) HUMIRA may prevent further damage to your bones and joints and may help your ability to perform daily activities. Moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in children 2 years of age and older. HUMIRA can be used alone or with methotrexate. Psoriatic arthritis (PsA) in adults.HUMIRA COMPLETE
HUMIRA can be used alone or with certain other medicines. HUMIRA may prevent further damage to your bones and joints and may help your ability to perform daily activities. Ankylosing spondylitis (AS) in adults. Moderate to severe hidradenitis suppurativa (HS) in people 12years and older.
HUMIRA® (ADALIMUMAB) FOR CHILDREN WITH ULCERATIVE COLITIS HUMIRA is the first and only treatment in its category that is FDA approved for pediatric ulcerative colitis (UC), and that can be administered at home after proper training by a health care professional. Over 1.4 million people worldwide are currently being treated with HUMIRA for different conditions. HUMIRA has been studiedfor more than 17
HUMIRA® (ADALIMUMAB) & NOVEL CORONAVIRUS (COVID-19) HUMIRA can cause serious side effects, including: Serious infections. These include TB and infections caused by viruses, fungi, or bacteria. Symptoms related to TB include a cough, low-grade fever, weight loss, or loss of body fat and muscle. Hepatitis B infection in carriers ofthe virus.
HUMIRA DOSING INFORMATION The starting dose of HUMIRA for adult patients with plaque psoriasis is 80 mg (milligrams) on Day 1 (2 Pens). The maintenance dose is 40 mg on Day 8 (1 Pen), and 40 mg every other week thereafter. Always follow your doctor's instructions about when and how often to take HUMIRA. If you need additional help with self-injecting, you can view an HUMIRA® (ADALIMUMAB) CITRATE-FREE INJECTION The latest HUMIRA presentation, Citrate-free, works just like original HUMIRA, but with less pain immediately following injection.*. The active ingredient (adalimumab) is the same as it has been for over 15 years. Other enhancements include a thinner needle and 50% less liquid to inject compared to original HUMIRA. HOW TO INJECT YOUR HUMIRA® (ADALIMUMAB) PEN OR SYRINGE Do not remove the gray or the plum-colored caps until right before your injection. When the plum-colored button on the HUMIRA Pen is pressed to give your dose of HUMIRA, you will hear a loud "click." The loud “click” means the injection has started. Injection is complete when the yellow indicator fully appears in the window viewand stops
IMPORTANT SAFETY INFORMATION Learn about the most common side effects of HUMIRA. Common side effects of HUMIRA include injection site reactions (pain, redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, rash, and nausea. These are not all of the possible side effects with HUMIRA. Tell your doctor if you haveany side
UVEITIS (UV) & HUMIRA® (ADALIMUMAB) HUMIRA can cause serious side effects, including: Serious infections. These include TB and infections caused by viruses, fungi, or bacteria. Symptoms related to TB include a cough, low-grade fever, weight loss, or loss of body fat and muscle. Hepatitis B infection in carriers ofthe virus.
FREQUENTLY ASKED QUESTIONS ABOUT HUMIRA (ADALIMUMAB) HUMIRA is a medicine called a tumor necrosis factor (TNF) blocker. HUMIRA targets and blocks TNF-alpha. TNF plays a role in the process that causes inflammation. Because TNF blockers, including HUMIRA, affect the immune system, they can lower the ability to fight infections and may cause other serious side effects.LOGIN - HUMIRA
HUMIRA is given by injection under the skin. This is the most important information to know about HUMIRA. For more information, talk to your health care provider. Uses. HUMIRA is a prescription medicine used: To reduce the signs and symptoms of: Moderate to severe rheumatoid arthritis (RA) in HUMIRA® (ADALIMUMAB) & NOVEL CORONAVIRUS (COVID-19) HUMIRA can cause serious side effects, including: Serious infections. These include TB and infections caused by viruses, fungi, or bacteria. Symptoms related to TB include a cough, low-grade fever, weight loss, or loss of body fat and muscle. Hepatitis B infection in carriers ofthe virus.
WHAT IS HUMIRA® (ADALIMUMAB): CROHN'S BIOLOGIC TREATMENT HUMIRA is a prescription medication administered by injection under the skin. You can administer it yourself in the comfort of your own home, either by a Pen or a prefilled syringe. By targeting and blocking a source of inflammation caused by moderate to severe Crohn’s disease, HUMIRA can help many adults achieve and maintainremission.
IMPORTANT SAFETY INFORMATION Learn about the most common side effects of HUMIRA. Common side effects of HUMIRA include injection site reactions (pain, redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, rash, and nausea. These are not all of the possible side effects with HUMIRA. Tell your doctor if you haveany side
HUMIRA COMPLETE ONGOING PATIENT SUPPORT HUMIRA can cause serious side effects, including: Serious infections. These include TB and infections caused by viruses, fungi, or bacteria. Symptoms related to TB include a cough, low-grade fever, weight loss, or loss of body fat and muscle. Hepatitis B infection in carriers ofthe virus.
IMPORTANT SAFETY INFORMATION HUMIRA can cause serious side effects, including: Serious infections. These include TB and infections caused by viruses, fungi, or bacteria. Symptoms related to TB include a cough, low-grade fever, weight loss, or loss of body fat and muscle. Hepatitis B infection in carriers of the virus. Symptoms include muscle aches, feeling very tired, dark CROHN’S DISEASE & HUMIRA® (ADALIMUMAB) HUMIRA may prevent further damage to your bones and joints and may help your ability to perform daily activities. Ankylosing spondylitis (AS) in adults. Moderate to severe hidradenitis suppurativa (HS) in people 12 years and older. To treat moderate to severe Crohn’s disease (CD) in adults and children 6 years of age and older. HUMIRA® (ADALIMUMAB) COST, COPAY, AND SAVINGS CARD The HUMIRA Complete Savings Card may reduce your cost for HUMIRA to as little as $5 a month, every month. * Get the Card Now. If your pharmacy is unable to process your HUMIRA Complete Savings Card for instant savings, you may still be able to get HUMIRA for as little as $5 a month by receiving a rebate for the amount you paid out of pocket for your prescription. FREQUENTLY ASKED QUESTIONS ABOUT HUMIRA (ADALIMUMAB) HUMIRA is a medicine called a tumor necrosis factor (TNF) blocker. HUMIRA targets and blocks TNF-alpha. TNF plays a role in the process that causes inflammation. Because TNF blockers, including HUMIRA, affect the immune system, they can lower the ability to fight infections and may cause other serious side effects. HUMIRA® (ADALIMUMAB) PATIENT RESOURCES HUMIRA Complete has one goal: to provide you with the resources you need—when you need them. Whether it’s injection training, helping you set up medication reminders, or a convenient mail-back kit to properly dispose of your used HUMIRA Pens and syringes, HUMIRAComplete makes it
HUMIRA® (ADALIMUMAB) HUMIRA may prevent further damage to your bones and joints and may help your ability to perform daily activities. Moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in children 2 years of age and older. HUMIRA can be used alone or with methotrexate. Psoriatic arthritis (PsA) in adults.LOGIN - HUMIRA
HUMIRA is given by injection under the skin. This is the most important information to know about HUMIRA. For more information, talk to your health care provider. Uses. HUMIRA is a prescription medicine used: To reduce the signs and symptoms of: Moderate to severe rheumatoid arthritis (RA) in HUMIRA® (ADALIMUMAB) FOR CHILDREN WITH ULCERATIVE COLITIS HUMIRA is the first and only treatment in its category that is FDA approved for pediatric ulcerative colitis (UC), and that can be administered at home after proper training by a health care professional. Over 1.4 million people worldwide are currently being treated with HUMIRA for different conditions. HUMIRA has been studiedfor more than 17
HUMIRA® (ADALIMUMAB) FOR ULCERATIVE COLITIS: DOSING AND HUMIRA dosing information for UC. The important difference between your starting and maintenance doses. When you begin taking HUMIRA, your doctor will prescribe you a loading or a starter dose, which is a higher dose, to quickly reach an effective concentration of medicinein your body.
HUMIRA® (ADALIMUMAB) FOR CROHN'S DOSING AND INJECTION Getting started with HUMIRA Citrate-free dosing. Starting Dose Day 1*. 2 HUMIRA 80 mg/0.8 mL Pens (160 mg) Starting Dose Day 15. 1 HUMIRA 80 mg/0.8 mL Pen (80 mg) *First dose can be administered as 2 injections in 1 day or as 1 injection per day for 2 consecutive days. HUMIRA DOSING INFORMATION The starting dose of HUMIRA for adult patients with plaque psoriasis is 80 mg (milligrams) on Day 1 (2 Pens). The maintenance dose is 40 mg on Day 8 (1 Pen), and 40 mg every other week thereafter. Always follow your doctor's instructions about when and how often to take HUMIRA. If you need additional help with self-injecting, you can view an IMPORTANT SAFETY INFORMATION Learn about the most common side effects of HUMIRA. Common side effects of HUMIRA include injection site reactions (pain, redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, rash, and nausea. These are not all of the possible side effects with HUMIRA. Tell your doctor if you haveany side
HOW TO INJECT YOUR HUMIRA® (ADALIMUMAB) PEN OR SYRINGE Do not remove the gray or the plum-colored caps until right before your injection. When the plum-colored button on the HUMIRA Pen is pressed to give your dose of HUMIRA, you will hear a loud "click." The loud “click” means the injection has started. Injection is complete when the yellow indicator fully appears in the window viewand stops
FREQUENTLY ASKED QUESTIONS ABOUT HUMIRA (ADALIMUMAB) HUMIRA is a medicine called a tumor necrosis factor (TNF) blocker. HUMIRA targets and blocks TNF-alpha. TNF plays a role in the process that causes inflammation. Because TNF blockers, including HUMIRA, affect the immune system, they can lower the ability to fight infections and may cause other serious side effects. SAFETY CONSIDERATIONS Signs and symptoms include numbness or tingling, problems with your vision, weakness in your arms or legs, and dizziness. Blood problems (decreased blood cells that help fight infections or stop bleeding). Symptoms include a fever that does not go away, bruising or bleeding very easily, or looking very pale. HUMIRA® (ADALIMUMAB) HUMIRA may prevent further damage to your bones and joints and may help your ability to perform daily activities. Moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in children 2 years of age and older. HUMIRA can be used alone or with methotrexate. Psoriatic arthritis (PsA) in adults.LOGIN - HUMIRA
HUMIRA is given by injection under the skin. This is the most important information to know about HUMIRA. For more information, talk to your health care provider. Uses. HUMIRA is a prescription medicine used: To reduce the signs and symptoms of: Moderate to severe rheumatoid arthritis (RA) in HUMIRA® (ADALIMUMAB) FOR CHILDREN WITH ULCERATIVE COLITIS HUMIRA is the first and only treatment in its category that is FDA approved for pediatric ulcerative colitis (UC), and that can be administered at home after proper training by a health care professional. Over 1.4 million people worldwide are currently being treated with HUMIRA for different conditions. HUMIRA has been studiedfor more than 17
HUMIRA® (ADALIMUMAB) FOR ULCERATIVE COLITIS: DOSING AND HUMIRA dosing information for UC. The important difference between your starting and maintenance doses. When you begin taking HUMIRA, your doctor will prescribe you a loading or a starter dose, which is a higher dose, to quickly reach an effective concentration of medicinein your body.
HUMIRA® (ADALIMUMAB) FOR CROHN'S DOSING AND INJECTION Getting started with HUMIRA Citrate-free dosing. Starting Dose Day 1*. 2 HUMIRA 80 mg/0.8 mL Pens (160 mg) Starting Dose Day 15. 1 HUMIRA 80 mg/0.8 mL Pen (80 mg) *First dose can be administered as 2 injections in 1 day or as 1 injection per day for 2 consecutive days. HUMIRA DOSING INFORMATION The starting dose of HUMIRA for adult patients with plaque psoriasis is 80 mg (milligrams) on Day 1 (2 Pens). The maintenance dose is 40 mg on Day 8 (1 Pen), and 40 mg every other week thereafter. Always follow your doctor's instructions about when and how often to take HUMIRA. If you need additional help with self-injecting, you can view an IMPORTANT SAFETY INFORMATION Learn about the most common side effects of HUMIRA. Common side effects of HUMIRA include injection site reactions (pain, redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, rash, and nausea. These are not all of the possible side effects with HUMIRA. Tell your doctor if you haveany side
HOW TO INJECT YOUR HUMIRA® (ADALIMUMAB) PEN OR SYRINGE Do not remove the gray or the plum-colored caps until right before your injection. When the plum-colored button on the HUMIRA Pen is pressed to give your dose of HUMIRA, you will hear a loud "click." The loud “click” means the injection has started. Injection is complete when the yellow indicator fully appears in the window viewand stops
FREQUENTLY ASKED QUESTIONS ABOUT HUMIRA (ADALIMUMAB) HUMIRA is a medicine called a tumor necrosis factor (TNF) blocker. HUMIRA targets and blocks TNF-alpha. TNF plays a role in the process that causes inflammation. Because TNF blockers, including HUMIRA, affect the immune system, they can lower the ability to fight infections and may cause other serious side effects. SAFETY CONSIDERATIONS Signs and symptoms include numbness or tingling, problems with your vision, weakness in your arms or legs, and dizziness. Blood problems (decreased blood cells that help fight infections or stop bleeding). Symptoms include a fever that does not go away, bruising or bleeding very easily, or looking very pale.LOGIN - HUMIRA
HUMIRA is given by injection under the skin. This is the most important information to know about HUMIRA. For more information, talk to your health care provider. Uses. HUMIRA is a prescription medicine used: To reduce the signs and symptoms of: Moderate to severe rheumatoid arthritis (RA) inHUMIRA COMPLETE
HUMIRA can be used alone or with certain other medicines. HUMIRA may prevent further damage to your bones and joints and may help your ability to perform daily activities. Ankylosing spondylitis (AS) in adults. Moderate to severe hidradenitis suppurativa (HS) in people 12years and older.
WHAT IS HUMIRA® (ADALIMUMAB): CROHN'S BIOLOGIC TREATMENT HUMIRA is a prescription medication administered by injection under the skin. You can administer it yourself in the comfort of your own home, either by a Pen or a prefilled syringe. By targeting and blocking a source of inflammation caused by moderate to severe Crohn’s disease, HUMIRA can help many adults achieve and maintainremission.
HUMIRA® (ADALIMUMAB) CITRATE-FREE INJECTION The latest HUMIRA presentation, Citrate-free, works just like original HUMIRA, but with less pain immediately following injection.*. The active ingredient (adalimumab) is the same as it has been for over 15 years. Other enhancements include a thinner needle and 50% less liquid to inject compared to original HUMIRA. CROHN’S DISEASE & HUMIRA® (ADALIMUMAB) HUMIRA may prevent further damage to your bones and joints and may help your ability to perform daily activities. Ankylosing spondylitis (AS) in adults. Moderate to severe hidradenitis suppurativa (HS) in people 12 years and older. To treat moderate to severe Crohn’s disease (CD) in adults and children 6 years of age and older. FREQUENTLY ASKED QUESTIONS ABOUT HUMIRA (ADALIMUMAB) HUMIRA is a medicine called a tumor necrosis factor (TNF) blocker. HUMIRA targets and blocks TNF-alpha. TNF plays a role in the process that causes inflammation. Because TNF blockers, including HUMIRA, affect the immune system, they can lower the ability to fight infections and may cause other serious side effects. HUMIRA® (ADALIMUMAB) PATIENT RESOURCES HUMIRA Complete has one goal: to provide you with the resources you need—when you need them. Whether it’s injection training, helping you set up medication reminders, or a convenient mail-back kit to properly dispose of your used HUMIRA Pens and syringes, HUMIRAComplete makes it
SAFETY CONSIDERATIONS Signs and symptoms include numbness or tingling, problems with your vision, weakness in your arms or legs, and dizziness. Blood problems (decreased blood cells that help fight infections or stop bleeding). Symptoms include a fever that does not go away, bruising or bleeding very easily, or looking very pale. ANKYLOSING SPONDYLITIS & HUMIRA® (ADALIMUMAB) HUMIRA may prevent further damage to your bones and joints and may help your ability to perform daily activities. Ankylosing spondylitis (AS) in adults. Moderate to severe hidradenitis suppurativa (HS) in people 12 years and older. To treat moderate to severe Crohn’s disease (CD) in adults and children 6 years of age and older. HUMIRA® (ADALIMUMAB) SAVINGS CARD Supplemental (Part D) is a stand-alone prescription drug plan that’s added to your Medicare Part A and Part B benefits to cover medications, such as HUMIRA. Call your plan directly or call our Insurance Specialists at 1.800.4HUMIRA (1.800.448.6472) to see if HUMIRA is covered under your plan. Skip to main content __*
Choose Condition __
* Choose Condition __ * Moderate to Severe Rheumatoid Arthritis * Moderate to Severe Chronic Plaque Psoriasis * Moderate to Severe Crohn's Disease * Moderate to Severe Pediatric Crohn's Disease * Moderate to Severe Ulcerative Colitis * Psoriatic Arthritis * Moderate to Severe Hidradenitis Suppurativa * Ankylosing Spondylitis * Moderate to Severe Polyarticular Juvenile Idiopathic Arthritis * Non-Infectious Intermediate, Posterior, and Panuveitis*
Important Safety Information __*
Full Prescribing Information & Patient Information __ * Full Prescribing Information & Patient Information __ * __ Full Prescribing Information (English) * __ Full Prescribing Information (En Español) * __ Medication Guide* Close
*
Health Care Professionals __Menu __ __
Sign in or Register
__
__
__
= $ctrl.searchAuthorConfigs.keywordLength" ng-class="{'auto-suggestions-display':$ctrl.searchText==='','auto-suggestions-display':$ctrl.searchText===undefined, 'auto-suggestions':$ctrl.searchText.length>=$ctrl.searchAuthorConfigs.keywordLength}"aria-hidden="true">
* __ HOME
* LEARN ABOUT HUMIRA____*
Moderate to Severe Rheumatoid Arthritis*
Moderate to Severe Chronic Plaque Psoriasis*
Moderate to Severe Crohn's Disease*
Moderate to Severe Pediatric Crohn's Disease*
Moderate to Severe Ulcerative Colitis*
Psoriatic Arthritis
*
Moderate to Severe Hidradenitis Suppurativa*
Ankylosing Spondylitis*
Moderate to Severe Polyarticular Juvenile Idiopathic Arthritis*
Non-Infectious Intermediate, Posterior, and Panuveitis * STARTING HUMIRA____*
About HUMIRA Complete*
Resources for You
*
Save on HUMIRA
*
Check Your Insurance Coverage*
Insurance Explained
*
Your HUMIRA Ambassador*
How to Inject HUMIRA*
Sign Up for HUMIRA Complete * CONTINUE TREATMENT____*
Complete Resource Center*
Sign In or Register
*
Contact Your Ambassador*
Get Your Savings Card*
Get Your Resources
*
Manage Medication Reminders*
Update Your Information Sign in or Register ____
LEARN ABOUT HUMIRA
* Moderate to Severe Rheumatoid Arthritis * Moderate to Severe Chronic Plaque Psoriasis * Moderate to Severe Crohn's Disease * Moderate to Severe Pediatric Crohn's Disease * Moderate to Severe Ulcerative Colitis * Psoriatic Arthritis * Moderate to Severe Hidradenitis Suppurativa * Ankylosing Spondylitis * Moderate to Severe Polyarticular Juvenile Idiopathic Arthritis * Non-Infectious Intermediate, Posterior, and PanuveitisSTARTING HUMIRA
* About HUMIRA Complete* Resources for You
* Save on HUMIRA
* Check Your Insurance Coverage * Insurance Explained * Your HUMIRA Ambassador * How to Inject HUMIRA * Sign Up for HUMIRA CompleteCONTINUE TREATMENT
* Complete Resource Center * Sign In or Register * Contact Your Ambassador * Get Your Savings Card * Get Your Resources * Manage Medication Reminders * Update Your Information__
Reimagine possible.
HUMIRA treats people who have: CHOOSE YOUR CONDITION __ __Moderate to Severe
Rheumatoid ArthritisPsoriatic Arthritis
Moderate to Severe ChronicPlaque Psoriasis
Moderate to Severe
Hidradenitis SuppurativaModerate to Severe
Crohn's Disease
Ankylosing SpondylitisModerate to Severe
Pediatric Crohn's Disease Moderate to Severe Polyarticular Juvenile Idiopathic ArthritisModerate to Severe
Ulcerative Colitis
Intermediate, Posterior, and Panuveitis Non-Infectious Uveitis__
Personalized, one-on-one, dedicated resources to help you start and stay on track on HUMIRA. Personalized Resources Monthly Savings on HUMIRA__
Personalized, one-on-one, dedicated resources to help you start and stay on track on HUMIRA. Personalized Resources Monthly Savings on HUMIRA IMPORTANT SAFETY INFORMATION ABOUT HUMIRA® (ADALIMUMAB)1 WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT HUMIRA? You should discuss the potential benefits and risks of HUMIRA with your doctor. HUMIRA is a TNF blocker medicine that can lower the ability of your immune system to fight infections. You should not start taking HUMIRA if you have any kind of infection unless your doctor says it is okay. * SERIOUS INFECTIONS HAVE HAPPENED IN PEOPLE TAKING HUMIRA. THESE SERIOUS INFECTIONS INCLUDE TUBERCULOSIS (TB) AND INFECTIONS CAUSED BY VIRUSES, FUNGI, OR BACTERIA THAT HAVE SPREAD THROUGHOUT THE BODY. SOME PEOPLE HAVE DIED FROM THESE INFECTIONS. Your doctor should test you for TB before starting HUMIRA, and check you closely for signs and symptoms of TB during treatment with HUMIRA, even if your TB test was negative. If your doctor feels you are at risk, you may be treated with medicine for TB. * CANCER. For children and adults taking TNF blockers, including HUMIRA, the chance of getting lymphoma or other cancers may increase. There have been cases of unusual cancers in children, teenagers, and young adults using TNF blockers. Some people have developed a rare type of cancer called hepatosplenic T-cell lymphoma. This type of cancer often results in death. If using TNF blockers including HUMIRA, your chance of getting two types of skin cancer (basal cell and squamous cell) may increase. These types are generally not life-threatening if treated; tell your doctor if you have a bump or open sore that doesn’t heal. WHAT SHOULD I TELL MY DOCTOR BEFORE STARTING HUMIRA? TELL YOUR DOCTOR ABOUT ALL OF YOUR HEALTH CONDITIONS, including ifyou:
* Have an infection, are being treated for infection, or have symptoms of an infection * Get a lot of infections or infections that keep coming back* Have diabetes
* Have TB or have been in close contact with someone with TB, or were born in, lived in, or traveled where there is more risk forgetting TB
* Live or have lived in an area (such as the Ohio and Mississippi River valleys) where there is an increased risk for getting certain kinds of fungal infections, such as histoplasmosis, coccidioidomycosis, or blastomycosis. These infections may happen or become more severe if you use HUMIRA. Ask your doctor if you are unsure if you have lived in these areas * Have or have had hepatitis B * Are scheduled for major surgery * Have or have had cancer * Have numbness or tingling or a nervous system disease such as multiple sclerosis or Guillain-Barré syndrome * Have or had heart failure * Have recently received or are scheduled to receive a vaccine. HUMIRA patients may receive vaccines, except for live vaccines. Children should be brought up to date on all vaccines before startingHUMIRA
* Are allergic to rubber, latex, or any HUMIRA ingredients * Are pregnant, planning to become pregnant, breastfeeding, or planning to breastfeed * Have a baby and you were using HUMIRA during your pregnancy. Tell your baby’s doctor before your baby receives any vaccines ALSO TELL YOUR DOCTOR ABOUT ALL THE MEDICINES YOU TAKE. You should not take HUMIRA with ORENCIA® (abatacept), KINERET® (anakinra), REMICADE® (infliximab), ENBREL® (etanercept), CIMZIA® (certolizumab pegol), or SIMPONI® (golimumab). Tell your doctor if you have ever used RITUXAN® (rituximab), IMURAN® (azathioprine), or PURINETHOL® (mercaptopurine, 6-MP). WHAT SHOULD I WATCH FOR AFTER STARTING HUMIRA? HUMIRA CAN CAUSE SERIOUS SIDE EFFECTS, including: * SERIOUS INFECTIONS. These include TB and infections caused by viruses, fungi, or bacteria. Symptoms related to TB include a cough, low-grade fever, weight loss, or loss of body fat and muscle. * HEPATITIS B INFECTION IN CARRIERS OF THE VIRUS. Symptoms include muscle aches, feeling very tired, dark urine, skin or eyes that look yellow, little or no appetite, vomiting, clay-colored bowel movements, fever, chills, stomach discomfort, and skin rash. * ALLERGIC REACTIONS. Symptoms of a serious allergic reaction include hives, trouble breathing, and swelling of your face, eyes,lips, or mouth.
* NERVOUS SYSTEM PROBLEMS. Signs and symptoms include numbness or tingling, problems with your vision, weakness in your arms or legs,and dizziness.
* BLOOD PROBLEMS (decreased blood cells that help fight infections or stop bleeding). Symptoms include a fever that does not go away, bruising or bleeding very easily, or looking very pale. * HEART FAILURE (new or worsening). Symptoms include shortness of breath, swelling of your ankles or feet, and sudden weight gain. * IMMUNE REACTIONS INCLUDING A LUPUS-LIKE SYNDROME. Symptoms include chest discomfort or pain that does not go away, shortness of breath, joint pain, or rash on your cheeks or arms that gets worse inthe sun.
* LIVER PROBLEMS. Symptoms include feeling very tired, skin or eyes that look yellow, poor appetite or vomiting, and pain on the right side of your stomach (abdomen). These problems can lead to liverfailure and death.
* PSORIASIS (new or worsening). Symptoms include red scaly patches or raised bumps that are filled with pus. CALL YOUR DOCTOR OR GET MEDICAL CARE RIGHT AWAY IF YOU DEVELOP ANY OFTHE ABOVE SYMPTOMS.
COMMON SIDE EFFECTS OF HUMIRA INCLUDE INJECTION SITE REACTIONS (pain, redness, rash, swelling, itching, or bruising), UPPER RESPIRATORY INFECTIONS (sinus infections), HEADACHES, RASH, and NAUSEA. These are not all of the possible side effects with HUMIRA. Tell your doctor if you have any side effect that bothers you or that does not go away. REMEMBER, TELL YOUR DOCTOR RIGHT AWAY IF YOU HAVE AN INFECTION OR SYMPTOMS OF AN INFECTION, INCLUDING: * Fever, sweats, or chills* Muscle aches
* Cough
* Shortness of breath* Blood in phlegm
* Weight loss
* Warm, red, or painful skin or sores on your body * Diarrhea or stomach pain * Burning when you urinate * Urinating more often than normal * Feeling very tired HUMIRA IS GIVEN BY INJECTION UNDER THE SKIN. THIS IS THE MOST IMPORTANT INFORMATION TO KNOW ABOUT HUMIRA. FOR MORE INFORMATION, TALK TO YOUR HEALTH CARE PROVIDER.USES
HUMIRA is a prescription medicine used: * TO REDUCE THE SIGNS AND SYMPTOMS OF: * MODERATE TO SEVERE RHEUMATOID ARTHRITIS (RA) in adults. HUMIRA can be used alone, with methotrexate, or with certain other medicines. HUMIRA may prevent further damage to your bones and joints and may help your ability to perform daily activities. * MODERATE TO SEVERE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS (JIA) in children 2 years of age and older. HUMIRA can be used alone, with methotrexate, or with certain other medicines. * PSORIATIC ARTHRITIS (PSA) in adults. HUMIRA can be used alone or with certain other medicines. HUMIRA may prevent further damage to your bones and joints and may help your ability to perform dailyactivities.
* ANKYLOSING SPONDYLITIS (AS) in adults. * MODERATE TO SEVERE CROHN'S DISEASE (CD) and to achieve and maintain clinical remission in adults who have not responded well to certain other medications. HUMIRA is also used to reduce signs and symptoms and to achieve clinical remission in these adults who have lost response to or are unable to tolerate infliximab. * MODERATE TO SEVERE CROHN'S DISEASE (CD) and to achieve and maintain clinical remission in children 6 years of age and older when certain other treatments have not worked well enough. * MODERATE TO SEVERE HIDRADENITIS SUPPURATIVA (HS) IN PEOPLE 12YEARS AND OLDER.
* IN ADULTS, TO HELP GET MODERATE TO SEVERE ULCERATIVE COLITIS (UC) under control (induce remission) and keep it under control (sustain remission) when certain other medicines have not worked well enough. It is not known if HUMIRA is effective in people who stopped responding to or could not tolerate anti-TNF medicines. * TO TREAT MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS (PS) in adults who are ready for systemic therapy or phototherapy, and are under the care of a doctor who will decide if other systemic therapies are less appropriate. * TO TREAT NON-INFECTIOUS INTERMEDIATE (middle part of the eye), POSTERIOR (back of the eye), AND PANUVEITIS (all parts of the eye) (UV) in adults and children 2 years of age and older.US-HUM-181696
PLEASE SEE THE FULL PRESCRIBING INFORMATION , INCLUDING THE MEDICATIONGUIDE , FOR HUMIRA.
YOU ARE ENCOURAGED TO REPORT NEGATIVE SIDE EFFECTS OF PRESCRIPTION DRUGS TO THE FDA. VISIT WWW.FDA.GOV/MEDWATCHOR CALL
1-800-FDA-1088.
IF YOU ARE HAVING DIFFICULTY PAYING FOR YOUR MEDICINE, ABBVIE MAY BE ABLE TO HELP. VISIT ABBVIE.COM/MYABBVIEASSISTTO LEARN MORE.
Legal Notices/Privacy Policy. Copyright 2013, AbbVie Inc., North Chicago, Illinois, U.S.A. If you have any questions about AbbVie’s HUMIRA.com website that have not been answered click here. This website and
the information contained herein is intended for use by US residents only, is provided for informational purposes only and is not intended to replace a discussion with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider and consider the unique characteristics of each patient. REFERENCE: 1. HUMIRA Injection . North Chicago, IL:AbbVie Inc.
US-HUM-190197
CONDITIONS HUMIRA TREATS * Moderate to Severe Rheumatoid Arthritis * Moderate to Severe Chronic Plaque Psoriasis * Moderate to Severe Crohn's Disease * Moderate to Severe Pediatric Crohn's Disease * Moderate to Severe Ulcerative Colitis * Psoriatic Arthritis * Moderate to Severe Hidradenitis Suppurativa * Ankylosing Spondylitis * Moderate to Severe Polyarticular Juvenile Idiopathic Arthritis * Non-Infectious Intermediate, Posterior, and Panuveitis * About HUMIRA Complete * Complete Resource Center IMPORTANT SAFETY INFORMATION FOR PATIENTS * Important Safety Information* Medication Guide
* Full Prescribing Information * Información en Español INFORMATION FROM ABBVIE* Contact Us
* Privacy Policy
* Terms of Use
* Advertising Choices * Health Care Professional Site2013 AbbVie Inc.
__ __
IMPORTANT SAFETY INFORMATION1 You should not start taking HUMIRA if you have any kind of infection unless your doctor says it is okay. SERIOUS INFECTIONS HAVE HAPPENED IN PEOPLE TAKING HUMIRA. THESE SERIOUS INFECTIONS INCLUDE TUBERCULOSIS (TB) AND INFECTIONS CAUSED BY VIRUSES, FUNGI, OR BACTERIA THAT HAVE SPREAD THROUGHOUT THE BODY. SOME PEOPLE HAVE DIED FROM THESE INFECTIONS. Your doctor should test you for TB before starting HUMIRA, and check you closely for signs and symptoms of TB during treatment with HUMIRA, even if your TB test was negative. If your doctor feels you are at risk, you may be treated with medicine for TB. CANCER. For children and adults taking TNF blockers, including HUMIRA, the chance of getting lymphoma or other cancers may increase. There have been cases of IMPORTANT SAFETY INFORMATION1 You should not start taking HUMIRA if you have any kind of infection unless your doctor says it is okay. SERIOUS INFECTIONS HAVE HAPPENED IN PEOPLE TAKING HUMIRA. THESE SERIOUS INFECTIONS INCLUDE TUBERCULOSIS (TB) AND INFECTIONS CAUSED BY VIRUSES, FUNGI, OR BACTERIA THAT HAVE SPREAD THROUGHOUT THE BODY. SOME PEOPLE HAVE DIED FROM THESE INFECTIONS. Your doctor should test you for TB before starting HUMIRA, and check you closely for signs and symptoms of TB during treatment with HUMIRA, even if your TB test was negative. If your doctor feels you are at risk, you may be treated with medicinefor TB.
IMPORTANT SAFETY INFORMATION1 You should not start taking HUMIRA if you have any kind of infection unless your doctor says it is okay. SERIOUS INFECTIONS HAVE HAPPENED IN PEOPLE TAKING HUMIRA. THESE SERIOUS INFECTIONS INCLUDE TUBERCULOSIS (TB) AND INFECTIONS CAUSED BY VIRUSES, FUNGI, OR BACTERIA THAT HAVE SPREAD THROUGHOUT THE BODY. SOME PEOPLE HAVE DIED FROM THESEINFECTIONS.
IMPORTANT SAFETY INFORMATION1 You should not start taking HUMIRA if you have any kind of infection unless your doctor says it is okay. SERIOUS INFECTIONS HAVE HAPPENED IN PEOPLE TAKING HUMIRA. THESE SERIOUS INFECTIONS INCLUDE IMPORTANT SAFETY INFORMATION ABOUT HUMIRA® (ADALIMUMAB)1 WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT HUMIRA? You should discuss the potential benefits and risks of HUMIRA with your doctor. HUMIRA is a TNF blocker medicine that can lower the ability of your immune system to fight infections. You should not start taking HUMIRA if you have any kind of infection unless your doctor says it is okay. * SERIOUS INFECTIONS HAVE HAPPENED IN PEOPLE TAKING HUMIRA. THESE SERIOUS INFECTIONS INCLUDE TUBERCULOSIS (TB) AND INFECTIONS CAUSED BY VIRUSES, FUNGI, OR BACTERIA THAT HAVE SPREAD THROUGHOUT THE BODY. SOME PEOPLE HAVE DIED FROM THESE INFECTIONS. Your doctor should test you for TB before starting HUMIRA, and check you closely for signs and symptoms of TB during treatment with HUMIRA, even if your TB test was negative. If your doctor feels you are at risk, you may be treated with medicine for TB. * CANCER. For children and adults taking TNF blockers, including HUMIRA, the chance of getting lymphoma or other cancers may increase. There have been cases of unusual cancers in children, teenagers, and young adults using TNF blockers. Some people have developed a rare type of cancer called hepatosplenic T-cell lymphoma. This type of cancer often results in death. If using TNF blockers including HUMIRA, your chance of getting two types of skin cancer (basal cell and squamous cell) may increase. These types are generally not life-threatening if treated; tell your doctor if you have a bump or open sore that doesn’t heal. WHAT SHOULD I TELL MY DOCTOR BEFORE STARTING HUMIRA? TELL YOUR DOCTOR ABOUT ALL OF YOUR HEALTH CONDITIONS, including ifyou:
* Have an infection, are being treated for infection, or have symptoms of an infection * Get a lot of infections or infections that keep coming back* Have diabetes
* Have TB or have been in close contact with someone with TB, or were born in, lived in, or traveled where there is more risk forgetting TB
* Live or have lived in an area (such as the Ohio and Mississippi River valleys) where there is an increased risk for getting certain kinds of fungal infections, such as histoplasmosis, coccidioidomycosis, or blastomycosis. These infections may happen or become more severe if you use HUMIRA. Ask your doctor if you are unsure if you have lived in these areas * Have or have had hepatitis B * Are scheduled for major surgery * Have or have had cancer * Have numbness or tingling or a nervous system disease such as multiple sclerosis or Guillain-Barré syndrome * Have or had heart failure * Have recently received or are scheduled to receive a vaccine. HUMIRA patients may receive vaccines, except for live vaccines. Children should be brought up to date on all vaccines before startingHUMIRA
* Are allergic to rubber, latex, or any HUMIRA ingredients * Are pregnant, planning to become pregnant, breastfeeding, or planning to breastfeed * Have a baby and you were using HUMIRA during your pregnancy. Tell your baby’s doctor before your baby receives any vaccines ALSO TELL YOUR DOCTOR ABOUT ALL THE MEDICINES YOU TAKE. You should not take HUMIRA with ORENCIA® (abatacept), KINERET® (anakinra), REMICADE® (infliximab), ENBREL® (etanercept), CIMZIA® (certolizumab pegol), or SIMPONI® (golimumab). Tell your doctor if you have ever used RITUXAN® (rituximab), IMURAN® (azathioprine), or PURINETHOL® (mercaptopurine, 6-MP). WHAT SHOULD I WATCH FOR AFTER STARTING HUMIRA? HUMIRA CAN CAUSE SERIOUS SIDE EFFECTS, including: * SERIOUS INFECTIONS. These include TB and infections caused by viruses, fungi, or bacteria. Symptoms related to TB include a cough, low-grade fever, weight loss, or loss of body fat and muscle. * HEPATITIS B INFECTION IN CARRIERS OF THE VIRUS. Symptoms include muscle aches, feeling very tired, dark urine, skin or eyes that look yellow, little or no appetite, vomiting, clay-colored bowel movements, fever, chills, stomach discomfort, and skin rash. * ALLERGIC REACTIONS. Symptoms of a serious allergic reaction include hives, trouble breathing, and swelling of your face, eyes,lips, or mouth.
* NERVOUS SYSTEM PROBLEMS. Signs and symptoms include numbness or tingling, problems with your vision, weakness in your arms or legs,and dizziness.
* BLOOD PROBLEMS (decreased blood cells that help fight infections or stop bleeding). Symptoms include a fever that does not go away, bruising or bleeding very easily, or looking very pale. * HEART FAILURE (new or worsening). Symptoms include shortness of breath, swelling of your ankles or feet, and sudden weight gain. * IMMUNE REACTIONS INCLUDING A LUPUS-LIKE SYNDROME. Symptoms include chest discomfort or pain that does not go away, shortness of breath, joint pain, or rash on your cheeks or arms that gets worse inthe sun.
* LIVER PROBLEMS. Symptoms include feeling very tired, skin or eyes that look yellow, poor appetite or vomiting, and pain on the right side of your stomach (abdomen). These problems can lead to liverfailure and death.
* PSORIASIS (new or worsening). Symptoms include red scaly patches or raised bumps that are filled with pus. CALL YOUR DOCTOR OR GET MEDICAL CARE RIGHT AWAY IF YOU DEVELOP ANY OFTHE ABOVE SYMPTOMS.
COMMON SIDE EFFECTS OF HUMIRA INCLUDE INJECTION SITE REACTIONS (pain, redness, rash, swelling, itching, or bruising), UPPER RESPIRATORY INFECTIONS (sinus infections), HEADACHES, RASH, and NAUSEA. These are not all of the possible side effects with HUMIRA. Tell your doctor if you have any side effect that bothers you or that does not go away. REMEMBER, TELL YOUR DOCTOR RIGHT AWAY IF YOU HAVE AN INFECTION OR SYMPTOMS OF AN INFECTION, INCLUDING: * Fever, sweats, or chills* Muscle aches
* Cough
* Shortness of breath* Blood in phlegm
* Weight loss
* Warm, red, or painful skin or sores on your body * Diarrhea or stomach pain * Burning when you urinate * Urinating more often than normal * Feeling very tired HUMIRA IS GIVEN BY INJECTION UNDER THE SKIN. THIS IS THE MOST IMPORTANT INFORMATION TO KNOW ABOUT HUMIRA. FOR MORE INFORMATION, TALK TO YOUR HEALTH CARE PROVIDER.USES
HUMIRA is a prescription medicine used: * TO REDUCE THE SIGNS AND SYMPTOMS OF: * MODERATE TO SEVERE RHEUMATOID ARTHRITIS (RA) in adults. HUMIRA can be used alone, with methotrexate, or with certain other medicines. HUMIRA may prevent further damage to your bones and joints and may help your ability to perform daily activities. * MODERATE TO SEVERE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS (JIA) in children 2 years of age and older. HUMIRA can be used alone, with methotrexate, or with certain other medicines. * PSORIATIC ARTHRITIS (PSA) in adults. HUMIRA can be used alone or with certain other medicines. HUMIRA may prevent further damage to your bones and joints and may help your ability to perform dailyactivities.
* ANKYLOSING SPONDYLITIS (AS) in adults. * MODERATE TO SEVERE CROHN'S DISEASE (CD) and to achieve and maintain clinical remission in adults who have not responded well to certain other medications. HUMIRA is also used to reduce signs and symptoms and to achieve clinical remission in these adults who have lost response to or are unable to tolerate infliximab. * MODERATE TO SEVERE CROHN'S DISEASE (CD) and to achieve and maintain clinical remission in children 6 years of age and older when certain other treatments have not worked well enough. * MODERATE TO SEVERE HIDRADENITIS SUPPURATIVA (HS) IN PEOPLE 12YEARS AND OLDER.
* IN ADULTS, TO HELP GET MODERATE TO SEVERE ULCERATIVE COLITIS (UC) under control (induce remission) and keep it under control (sustain remission) when certain other medicines have not worked well enough. It is not known if HUMIRA is effective in people who stopped responding to or could not tolerate anti-TNF medicines. * TO TREAT MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS (PS) in adults who are ready for systemic therapy or phototherapy, and are under the care of a doctor who will decide if other systemic therapies are less appropriate. * TO TREAT NON-INFECTIOUS INTERMEDIATE (middle part of the eye), POSTERIOR (back of the eye), AND PANUVEITIS (all parts of the eye) (UV) in adults and children 2 years of age and older.US-HUM-181696
Loading...
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0